Using doxycycline for prophylaxis of bacterial sexually transmitted infections: considerations for the European Union and European Economic Area

References

1. Evers YJ, van Liere GAFS, Dukers-Muijrers NHTM, Hoebe CJPA. Use of doxycycline and other antibiotics to prevent STIs among men who have sex with men visiting sexual health clinics in the Netherlands. Sex Transm Infect. 2020;96(7):550-1.  https://doi.org/10.1136/sextrans-2019-054325  PMID: 31879360 
2. Hornuss D, Mathé P, Usadel S, Zimmermann S, Müller M, Rieg S. Already current practice? A snapshot survey on doxycycline use for prevention of sexually transmitted infections in parts of the German MSM community. Infection. 2023.  https://doi.org/10.1007/s15010-023-02086-9  PMID: 37608042 
3. Bolan RK, Beymer MR, Weiss RE, Flynn RP, Leibowitz AA, Klausner JD. Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study. Sex Transm Dis. 2015;42(2):98-103.  https://doi.org/10.1097/OLQ.0000000000000216  PMID: 25585069 
4. Molina JM, Charreau I, Chidiac C, Pialoux G, Cua E, Delaugerre C, et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis. 2018;18(3):308-17.  https://doi.org/10.1016/S1473-3099(17)30725-9  PMID: 29229440 
5. Luetkemeyer AF, Donnell D, Dombrowski JC, Cohen S, Grabow C, Brown CE, et al. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. N Engl J Med. 2023;388(14):1296-306.  https://doi.org/10.1056/NEJMoa2211934  PMID: 37018493 
6. Molina JM, Bercot B, Assoumou L, Algarte-Genin M, Rubenstein E, Pialoux G, et al. Conference on Retroviruses and Opportunistic Infections (CROI). ANRS 174 DOXYVAC: An open-label randomized trial to prevent STIs in MSM on PrEP. Seattle: CROI. 19-22 Feb 2023.
7. Stewart J, Bukusi E, Sesay FA, Oware K, Donnell D, Soge OO, et al. Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial. Trials. 2022;23(1):495.  https://doi.org/10.1186/s13063-022-06458-8  PMID: 35710444 
8. Kenyon C, Gestels Z, Vanbaelen T, Abdellati S, Van Den Bossche D, De Baetselier I, et al. Doxycycline PEP can induce doxycycline resistance in Klebsiella pneumoniae in a Galleria mellonella model of PEP. Front Microbiol. 2023;14:1208014.  https://doi.org/10.3389/fmicb.2023.1208014  PMID: 37711686 
9. Thibaut V, Manoharan-Basil S, Kenyon C. 45 Years of tetracycline post exposure prophylaxis for STIs and the risk of tetracycline resistance: a systematic review and meta-analysis. Preprints; 2023. 2023092020.  https://doi.org/10.20944/preprints202309.2020.v1 
10. Harrison WO, Hooper RR, Wiesner PJ, Campbell AF, Karney WW, Reynolds GH, et al. A trial of minocycline given after exposure to prevent gonorrhea. N Engl J Med. 1979;300(19):1074-8.  https://doi.org/10.1056/NEJM197905103001903  PMID: 107450 
11. Truong R, Tang V, Grennan T, Tan DHS. A systematic review of the impacts of oral tetracycline class antibiotics on antimicrobial resistance in normal human flora. JAC Antimicrob Resist. 2022;4(1):dlac009.  https://doi.org/10.1093/jacamr/dlac009  PMID: 35198979 
12. Saarela M, Maukonen J, von Wright A, Vilpponen-Salmela T, Patterson AJ, Scott KP, et al. Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention. Int J Antimicrob Agents. 2007;29(3):271-80.  https://doi.org/10.1016/j.ijantimicag.2006.09.020  PMID: 17207972 
13. Chan PA, Le Brazidec DL, Becasen JS, Martin H, Kapadia J, Reno H, et al. Safety of Longer-Term Doxycycline Use: A Systematic Review and Meta-Analysis With Implications for Bacterial Sexually Transmitted Infection Chemoprophylaxis. Sex Transm Dis. 2023;50(11):701-12.  https://doi.org/10.1097/OLQ.0000000000001865  PMID: 37732844 
14. Centers for Disease Control and Prevention (CDC). Guidelines for the Use of Doxycycline Post-Exposure Prophylaxis for Bacterial STI Prevention. Atlanta: CDC. [Accessed: 9 Nov 2023]. Available from: https://www.cdc.gov/std/treatment/guidelines-for-doxycycline.htm
15. European AIDS Clinical Society (EACS). Guidelines version 12.0. Brussels: EACS. Oct 2023. Available from: https://www.eacsociety.org/media/guidelines-12.0.pdf